Dr Jules Mbuyamba is a medical doctor and clinical microbiology researcher based in the Democratic Republic of the Congo. He serves as Assistant in the Department of Microbiology at the University Clinics of Kinshasa and as physician-researcher in the Bacteriology and Research Unit at the Institut National de Recherche Biomédicale (INRB). His research focuses on clinical bacteriology, bloodstream infection surveillance, antimicrobial resistance (AMR), and infection control in resource-limited settings. He is actively involved in monitoring bacterial resistance patterns, conducting clinical trials, evaluating antimicrobial treatment efficacy, and developing evidence-based therapeutic strategies. His work emphasizes non-typhoidal Salmonella infections, multidrug-resistant pathogens, and optimization of empirical antibiotic therapy. Dr Mbuyamba has co-authored several peer-reviewed publications in international journals, including BMC Infectious Diseases, Frontiers in Medicine, The Lancet Infectious Diseases, and Clinical Microbiology and Infection. His recent studies cover epidemiology, resistance patterns of invasive bacterial infections, and efficacy of susceptibility-guided antibiotic treatments. He has a publication in Antibiotics on “Epidemiology, Temporal Trends and Resistance Patterns of ESBL-Producing Non-Typhoidal Salmonella Isolated from Blood Cultures in Kisantu, DRC (2019–2022)”. His research supports antimicrobial stewardship, strengthening laboratory and clinic